SCHEMBL5133695

SCHEMBL5133695

CCCc1nn(C)c2cnc(NCc3ccn(-c4ccccc4)n3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.41
CASR P41180 1/20 0.41
CYP1A2 P05177 7/20 0.36
CYP2C9 P11712 7/20 0.36
ALDH1A1 P00352 7/20 0.36
CASP1 P29466 6/20 0.36
CASP7 P55210 6/20 0.36
HSD17B10 Q99714 6/20 0.36
CYP3A4 P08684 6/20 0.36
CYP2D6 P10635 5/20 0.36
CYP2C19 P33261 5/20 0.36
HPGD P15428 5/20 0.36
USP2 O75604 5/20 0.36
TSHR P16473 3/20 0.36
ALOX15 P16050 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
BRCA1 P38398 1/20 0.36
MAPK1 P28482 3/20 0.35
TP53 P04637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5134599 0.79 MKNK1 (0.40) CYP1A2CYP2C9ALDH1A1CASP1CASP7
SCHEMBL4903517 0.75 PDE5A (0.55) CASRALDH1A1HPGDMEN1KMT2A
SCHEMBL5134598 0.72 TRPV1 (0.39) PDE5ACLK4
SCHEMBL29655227 0.69 PDE10A (0.56) PDE10ACASRCYP2C9ALDH1A1HSD17B10
SCHEMBL5133805 0.68 DRD1 (0.45) CYP2D6PDE5AKDM4E
SCHEMBL3122462 0.66 PDE5A (0.36) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL12890064 0.65 CASR (0.63) PDE10ACASRCYP2C9HSD17B10CYP3A4
SCHEMBL27603005 0.64 HDAC3 (0.57) PDE10ACASRCYP2C9HSD17B10TSHR
SCHEMBL12375939 0.63 CASR (0.55) PDE10ACASRCYP2C9HSD17B10CYP3A4
SCHEMBL27603032 0.63 HDAC3 (0.59) PDE10ACASRCYP2C9HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO claimed
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO disclosed